| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |